Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Wattel

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Blood|July 15, 1994
Prolonged follow-up confirms that all-trans retinoic acid followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia. The French APL GroupP Fenaux, E Wattel, E Archimbaud, et al.
Blood|January 15, 1998
Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletionY Sterkers, C Preudhomme, J L Laï, et al.
Leukemia & Lymphoma|December 29, 1999
Continuous-infusion carboplatin in combination with idarubicin or mitoxantrone for high-risk acute myeloid leukemia: a randomised phase II studyA Belhabri, X Thomas, J Troncy, et al.
Leukemia & Lymphoma|July 1, 1995
Good predictive value of combined cytogenetic and molecular follow up in chronic myelogenous leukemia after non T-cell depleted allogeneic bone marrow transplantation: a report on 38 consecutive casesC Preudhomme, E Wattel, J L Lai, et al.
British Journal of Haematology|June 3, 1999
Semiquantitative analysis of residual disease in patients treated for adult T-cell leukaemia/lymphoma (ATLL)I Leclercq, F Mortreux, F Morschhauser, et al.
Oncogene|October 24, 2000
High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasisA S Gabet, F Mortreux, A Talarmin, et al.
Revue De Laryngologie - Otologie - Rhinologie|June 18, 1999
[Elements of epidemiology and initiation of carcinogenesis in carcinomas of the upper aerodigestive tract. Future therapeutic consequence?]G Dolivet, P Colosetti, J L Merlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 casesC Preudhomme, I Dervite, E Wattel, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|July 14, 2012
Changes of mandibular ramal height, during growth in unilateral hemifacial microsomia patients and unaffected controlsE M Ongkosuwito, J van Vooren, J W van Neck, et al.
Cancer Research|December 1, 1988
Pharmacokinetics of 5-fluorouracil assessed with a sensitive mass spectrometric method in patients on a dose escalation scheduleC J van Groeningen, H M Pinedo, J Heddes, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Blood|July 15, 1994
Prolonged follow-up confirms that all-trans retinoic acid followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia. The French APL GroupP Fenaux, E Wattel, E Archimbaud, et al.
Blood|January 15, 1998
Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletionY Sterkers, C Preudhomme, J L Laï, et al.
Leukemia & Lymphoma|December 29, 1999
Continuous-infusion carboplatin in combination with idarubicin or mitoxantrone for high-risk acute myeloid leukemia: a randomised phase II studyA Belhabri, X Thomas, J Troncy, et al.
Leukemia & Lymphoma|July 1, 1995
Good predictive value of combined cytogenetic and molecular follow up in chronic myelogenous leukemia after non T-cell depleted allogeneic bone marrow transplantation: a report on 38 consecutive casesC Preudhomme, E Wattel, J L Lai, et al.
British Journal of Haematology|June 3, 1999
Semiquantitative analysis of residual disease in patients treated for adult T-cell leukaemia/lymphoma (ATLL)I Leclercq, F Mortreux, F Morschhauser, et al.
Oncogene|October 24, 2000
High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasisA S Gabet, F Mortreux, A Talarmin, et al.
Revue De Laryngologie - Otologie - Rhinologie|June 18, 1999
[Elements of epidemiology and initiation of carcinogenesis in carcinomas of the upper aerodigestive tract. Future therapeutic consequence?]G Dolivet, P Colosetti, J L Merlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 casesC Preudhomme, I Dervite, E Wattel, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|July 14, 2012
Changes of mandibular ramal height, during growth in unilateral hemifacial microsomia patients and unaffected controlsE M Ongkosuwito, J van Vooren, J W van Neck, et al.
Cancer Research|December 1, 1988
Pharmacokinetics of 5-fluorouracil assessed with a sensitive mass spectrometric method in patients on a dose escalation scheduleC J van Groeningen, H M Pinedo, J Heddes, et al.
Pageof 10